US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ABVC BioPharma, Inc.

0.8300

+0.03434.31%

Post-market: 0.87000.0400+4.82%19:30 EDT

Volume:94.14K

Turnover:78.20K

Market Cap:22.12M

PE:-2.91

High:0.8499

Open:0.8400

Low:0.8100

Close:0.7957

52wk High:3.40

52wk Low:0.7069

Shares:26.65M

Float Shares:21.83M

Volume Ratio:1.08

T/O Rate:0.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2855

EPS(LYR):-0.3933

ROE:-69.86%

ROA:-22.85%

PB:2.15

PE(LYR):-2.11

Loading ...

Overview Company News Filings

ABVC BioPharma delays filing quarterly report for period ended March 31, 2026

Press Release: Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301

Collegium Pharmaceutical Completes AZSTARYS ADHD Business Acquisition

Press Release: Collegium Completes Acquisition of AZSTARYS(R) from Corium Therapeutics

Yukiguni Maitake Sees FY Net Y2.54B

Press Release: Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress

Regencell Bioscience Holdings Faces Federal Securities Lawsuit Over Alleged Market Manipulation Disclosures

Alto Neuroscience presents Phase 2a data for ALTO-207 in MDD

Regencell Bioscience Holdings Faces Investor Lawsuit Alleging Securities Fraud Tied to DOJ Investigation and Stock Volatility

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Humanwell Healthcare Subsidiary Gets China Nod for ADHD Treatment

MT Newswires Live

ABVC BioPharma Shareholders Back Board, Equity Plan Changes

ABVC Biopharma held annual shareholder meeting; quorum reached with 10.6 million shares represented by proxy

Press Release: LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

Collegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating

Press Release: Collegium to Acquire AZSTARYS(R) from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory

Press Release: Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

ABVC posts FY 2025 net loss of USD 8.4 million (59% increase)

Abvc Biopharma Says Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon; Reports Material Weakness In Internal Controls Over Financial Reporting For FY25

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/ABVC/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABVC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVC\",,,,,undefined,":{"symbol":"ABVC","market":"US","secType":"STK","nameCN":"ABVC BioPharma, Inc.","latestPrice":0.83,"timestamp":1787947200000,"preClose":0.7957,"halted":0,"volume":94138,"hourTrading":{"tag":"盘后","latestPrice":0.87,"preClose":0.83,"latestTime":"19:30 EDT","volume":208,"amount":180.67,"timestamp":1787959805458,"change":0.04,"changeRate":0.048193,"amplitude":0.048193},"delay":0,"changeRate":0.04310669850446148,"floatShares":21826200,"shares":26654365,"eps":-0.285468,"marketStatus":"Market Closed","change":0.0343,"latestTime":"08-28 16:00:00 EDT","open":0.84,"high":0.8499,"low":0.81,"amount":78197.0664596,"amplitude":0.050145,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.285468,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"listingDate":1627963200000,"exchange":"NASDAQ","adjPreClose":0.7957,"preHourTrading":{"tag":"盘前","latestPrice":0.8,"preClose":0.7957,"latestTime":"08:36 EDT","volume":303,"amount":242.5851027,"timestamp":1787920611384,"change":0.0043,"changeRate":0.005404,"amplitude":0.077542},"postHourTrading":{"tag":"盘后","latestPrice":0.87,"preClose":0.83,"latestTime":"19:30 EDT","volume":208,"amount":180.67,"timestamp":1787959805458,"change":0.04,"changeRate":0.048193,"amplitude":0.048193},"volumeRatio":1.0834631976847537,"impliedVol":0.4964,"impliedVolPercentile":0.1315},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVC\",,,,,undefined,":{"symbol":"ABVC","floatShares":21826200,"roa":"-22.85%","roe":"-69.86%","lyrEps":-0.393285,"volumeRatio":1.0834631976847537,"shares":26654365,"dividePrice":0,"high":0.8499,"amplitude":0.050145,"preClose":0.7957,"low":0.81,"week52Low":0.7069,"pbRate":"2.15","psRate":"27.73","week52High":3.4,"institutionHeld":0,"latestPrice":0.83,"eps":-0.285468,"divideRate":0,"volume":94138,"delay":0,"ttmEps":-0.285468,"open":0.84,"prevYearClose":2.13,"prevWeekClose":0.8899,"prevMonthClose":1.01,"prevQuarterClose":1.58,"fiveDayClose":0.8899,"twentyDayClose":1.01,"sixtyDayClose":1.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABVC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"ABVC","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2026-05-18","symbol":"ABVC","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1779076800000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2026-03-03","symbol":"ABVC","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772514000000,"reportTimeType":"post","actualEps":-0.12},{"date":"2025-11-03","symbol":"ABVC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1762160400000,"name":null,"time":"Pre-MKt","dateTimestamp":1762146000000,"actualEps":null},{"market":"US","date":"2025-08-13","symbol":"ABVC","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABVC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABVC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABVC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABVC","date":"2026-08-28","current":-2.907506,"percent":0.428804,"low":-26.463766,"twenty":-7.951395,"median":-1.608071,"eighty":-0.794418,"high":-0.260274,"avg":-4.295887,"sd":4.779832,"marketCap":20627507},"quantilePoints":[{"date":"2021-09-03","current":-8.393504,"twenty":-100.840692,"median":-20.536178,"eighty":-12.981103,"marketCap":82209331},{"date":"2021-09-10","current":-8.290199,"twenty":-100.840692,"median":-20.327641,"eighty":-12.731467,"marketCap":81197524},{"date":"2021-09-17","current":-7.386283,"twenty":-100.840692,"median":-20.25282,"eighty":-12.48183,"marketCap":72344211},{"date":"2021-09-24","current":-6.404889,"twenty":-100.840692,"median":-20.249018,"eighty":-12.48183,"marketCap":62732043},{"date":"2021-10-01","current":-5.862539,"twenty":-100.840692,"median":-20.143991,"eighty":-12.48183,"marketCap":57420056},{"date":"2021-10-08","current":-5.578452,"twenty":-96.807064,"median":-20.052297,"eighty":-12.48183,"marketCap":54637586},{"date":"2021-10-15","current":-6.998891,"twenty":-95.798657,"median":-20.052297,"eighty":-12.48183,"marketCap":68549935},{"date":"2021-10-22","current":-6.379063,"twenty":-95.798657,"median":-20.02901,"eighty":-12.357012,"marketCap":62479092},{"date":"2021-10-29","current":-6.885086,"twenty":-95.798657,"median":-20.005723,"eighty":-12.332048,"marketCap":67435282},{"date":"2021-11-05","current":-10.164989,"twenty":-93.770452,"median":-19.95676,"eighty":-12.112235,"marketCap":99559965},{"date":"2021-11-12","current":-8.999403,"twenty":-93.263401,"median":-19.851774,"eighty":-11.72383,"marketCap":88143755},{"date":"2021-11-19","current":-9.556177,"twenty":-93.263401,"median":-19.851774,"eighty":-11.230993,"marketCap":93218994},{"date":"2021-11-26","current":-9.294762,"twenty":-93.263401,"median":-19.851774,"eighty":-11.139591,"marketCap":90668931},{"date":"2021-12-03","current":-8.510516,"twenty":-93.263401,"median":-19.450728,"eighty":-11.097077,"marketCap":83018740},{"date":"2021-12-10","current":-10.108053,"twenty":-90.465498,"median":-19.450728,"eighty":-11.097077,"marketCap":98602462},{"date":"2021-12-17","current":-10.398515,"twenty":-88.60023,"median":-19.450728,"eighty":-11.097077,"marketCap":101435866},{"date":"2021-12-23","current":-10.950391,"twenty":-88.60023,"median":-19.250205,"eighty":-11.042884,"marketCap":106819334},{"date":"2021-12-31","current":-9.846638,"twenty":-88.60023,"median":-18.803806,"eighty":-10.973777,"marketCap":96052398},{"date":"2022-01-07","current":-9.90473,"twenty":-88.60023,"median":-18.754997,"eighty":-10.850476,"marketCap":96619079},{"date":"2022-01-14","current":-9.556177,"twenty":-88.60023,"median":-18.687731,"eighty":-10.850476,"marketCap":93218994},{"date":"2022-01-21","current":-7.900547,"twenty":-88.60023,"median":-18.539338,"eighty":-10.850476,"marketCap":77068591},{"date":"2022-01-28","current":-7.174394,"twenty":-88.60023,"median":-18.52056,"eighty":-10.712213,"marketCap":69985081},{"date":"2022-02-04","current":-7.319625,"twenty":-88.60023,"median":-18.401426,"eighty":-10.554554,"marketCap":71401783},{"date":"2022-02-11","current":-7.668178,"twenty":-88.60023,"median":-18.286122,"eighty":-10.404324,"marketCap":74801868},{"date":"2022-02-18","current":-7.348671,"twenty":-88.60023,"median":-18.220695,"eighty":-10.343792,"marketCap":71685123},{"date":"2022-02-25","current":-7.116302,"twenty":-88.60023,"median":-18.188702,"eighty":-10.164989,"marketCap":69418400},{"date":"2022-03-04","current":-7.116302,"twenty":-88.60023,"median":-18.047067,"eighty":-9.98737,"marketCap":69418400},{"date":"2022-03-11","current":-6.622518,"twenty":-88.60023,"median":-18.047067,"eighty":-9.875684,"marketCap":64601613},{"date":"2022-03-18","current":-6.564425,"twenty":-88.60023,"median":-17.909889,"eighty":-9.788546,"marketCap":64034932},{"date":"2022-03-25","current":-7.029163,"twenty":-88.60023,"median":-17.850261,"eighty":-9.704796,"marketCap":68568379},{"date":"2022-04-01","current":-6.339112,"twenty":-88.60023,"median":-17.739319,"eighty":-9.704796,"marketCap":81386671},{"date":"2022-04-08","current":-6.31572,"twenty":-88.60023,"median":-17.732346,"eighty":-9.704796,"marketCap":81086351},{"date":"2022-04-14","current":-5.894672,"twenty":-88.60023,"median":-17.680293,"eighty":-9.60846,"marketCap":75680594},{"date":"2022-04-22","current":-5.754323,"twenty":-88.60023,"median":-17.646021,"eighty":-9.54452,"marketCap":73878675},{"date":"2022-04-29","current":-5.590582,"twenty":-88.60023,"median":-17.646021,"eighty":-9.360688,"marketCap":71776436},{"date":"2022-05-06","current":-5.766019,"twenty":-88.60023,"median":-17.646021,"eighty":-9.252091,"marketCap":74028835},{"date":"2022-05-13","current":-5.2631,"twenty":-88.60023,"median":-17.58281,"eighty":-9.119715,"marketCap":67571959},{"date":"2022-05-20","current":-3.799171,"twenty":-88.60023,"median":-17.545855,"eighty":-9.098246,"marketCap":67267162},{"date":"2022-05-27","current":-3.527801,"twenty":-88.60023,"median":-17.467267,"eighty":-9.097299,"marketCap":62462364},{"date":"2022-06-03","current":-3.744897,"twenty":-88.60023,"median":-17.373275,"eighty":-9.093511,"marketCap":66306202},{"date":"2022-06-10","current":-1.628216,"twenty":-88.60023,"median":-17.227608,"eighty":-8.989743,"marketCap":28828783},{"date":"2022-06-17","current":-1.764263,"twenty":-88.60023,"median":-17.146548,"eighty":-8.906096,"marketCap":31237588},{"date":"2022-06-24","current":-1.790857,"twenty":-88.60023,"median":-17.057037,"eighty":-8.85907,"marketCap":31708458},{"date":"2022-07-01","current":-1.82722,"twenty":-88.60023,"median":-17.057037,"eighty":-8.794971,"marketCap":32352301},{"date":"2022-07-08","current":-1.881494,"twenty":-88.60023,"median":-16.871014,"eighty":-8.794971,"marketCap":33313261},{"date":"2022-07-15","current":-1.415282,"twenty":-88.60023,"median":-16.641799,"eighty":-8.791309,"marketCap":25058619},{"date":"2022-07-22","current":-1.4189,"twenty":-88.60023,"median":-16.368319,"eighty":-8.790393,"marketCap":25122683},{"date":"2022-07-29","current":-1.175934,"twenty":-88.60023,"median":-16.201757,"eighty":-8.70552,"marketCap":20820788},{"date":"2022-08-05","current":-1.14735,"twenty":-88.60023,"median":-16.10474,"eighty":-8.638835,"marketCap":20314682},{"date":"2022-08-12","current":-1.212116,"twenty":-88.60023,"median":-15.910707,"eighty":-8.55118,"marketCap":21461427},{"date":"2022-08-19","current":-1.600085,"twenty":-88.60023,"median":-15.82702,"eighty":-8.491696,"marketCap":28150574},{"date":"2022-08-26","current":-1.546748,"twenty":-88.60023,"median":-15.82702,"eighty":-8.487276,"marketCap":27212221},{"date":"2022-09-02","current":-1.875961,"twenty":-88.60023,"median":-15.82702,"eighty":-8.487276,"marketCap":33004121},{"date":"2022-09-09","current":-2.023095,"twenty":-88.60023,"median":-15.82702,"eighty":-8.340059,"marketCap":35592680},{"date":"2022-09-16","current":-1.3426,"twenty":-88.60023,"median":-15.800641,"eighty":-8.303464,"marketCap":23620596},{"date":"2022-09-23","current":-1.680089,"twenty":-88.60023,"median":-15.762085,"eighty":-8.21272,"marketCap":29558103},{"date":"2022-09-30","current":-1.618476,"twenty":-88.60023,"median":-15.716674,"eighty":-8.036784,"marketCap":28474144},{"date":"2022-10-07","current":-1.626753,"twenty":-88.60023,"median":-15.610527,"eighty":-7.747849,"marketCap":28619750},{"date":"2022-10-14","current":-1.287424,"twenty":-88.60023,"median":-15.563236,"eighty":-7.670371,"marketCap":22649887},{"date":"2022-10-21","current":-1.324208,"twenty":-88.60023,"median":-15.563236,"eighty":-7.581872,"marketCap":23297027},{"date":"2022-10-28","current":-1.359888,"twenty":-88.60023,"median":-15.563236,"eighty":-7.479591,"marketCap":23924752},{"date":"2022-11-04","current":-1.348301,"twenty":-88.60023,"median":-15.563236,"eighty":-7.430234,"marketCap":23720903},{"date":"2022-11-11","current":-1.327151,"twenty":-88.60023,"median":-15.563236,"eighty":-7.386283,"marketCap":23348798},{"date":"2022-11-18","current":-1.231758,"twenty":-88.60023,"median":-15.563236,"eighty":-7.319625,"marketCap":24008880},{"date":"2022-11-25","current":-1.245038,"twenty":-88.60023,"median":-15.522641,"eighty":-7.302197,"marketCap":24267736},{"date":"2022-12-02","current":-1.269773,"twenty":-88.60023,"median":-15.497757,"eighty":-7.288183,"marketCap":24749855},{"date":"2022-12-09","current":-1.228438,"twenty":-88.60023,"median":-15.445794,"eighty":-7.272153,"marketCap":23944166},{"date":"2022-12-16","current":-1.162036,"twenty":-88.60023,"median":-15.329372,"eighty":-7.261532,"marketCap":22649887},{"date":"2022-12-23","current":-1.145435,"twenty":-88.60023,"median":-15.299453,"eighty":-7.226677,"marketCap":22326317},{"date":"2022-12-30","current":-1.037532,"twenty":-88.60023,"median":-15.199238,"eighty":-7.174394,"marketCap":20223113},{"date":"2023-01-06","current":-1.512141,"twenty":-88.133914,"median":-15.199238,"eighty":-7.100329,"marketCap":29473974},{"date":"2023-01-13","current":-1.435777,"twenty":-86.576754,"median":-15.134575,"eighty":-6.953369,"marketCap":27985521},{"date":"2023-01-20","current":-1.29484,"twenty":-85.538648,"median":-15.003998,"eighty":-6.821454,"marketCap":25238445},{"date":"2023-01-27","current":-1.261473,"twenty":-85.538648,"median":-14.852734,"eighty":-6.739858,"marketCap":24588070},{"date":"2023-02-03","current":-1.167182,"twenty":-85.538648,"median":-14.654339,"eighty":-6.646897,"marketCap":22750194},{"date":"2023-02-10","current":-1.245038,"twenty":-70.569383,"median":-14.475627,"eighty":-6.564425,"marketCap":24267736},{"date":"2023-02-17","current":-1.203539,"twenty":-70.569383,"median":-14.327911,"eighty":-6.471848,"marketCap":23458844},{"date":"2023-02-24","current":-1.161758,"twenty":-70.569383,"median":-14.296916,"eighty":-6.418638,"marketCap":22644477},{"date":"2023-03-03","current":-1.170116,"twenty":-70.569383,"median":-14.296916,"eighty":-6.368733,"marketCap":22807387},{"date":"2023-03-10","current":-0.98808,"twenty":-70.569383,"median":-14.296916,"eighty":-6.32741,"marketCap":19259209},{"date":"2023-03-17","current":-1.002957,"twenty":-70.569383,"median":-14.296916,"eighty":-6.222154,"marketCap":19549189},{"date":"2023-03-24","current":-1.019673,"twenty":-70.569383,"median":-14.118204,"eighty":-6.090777,"marketCap":19875009},{"date":"2023-03-31","current":-1.069821,"twenty":-70.569383,"median":-14.118204,"eighty":-5.965645,"marketCap":20852468},{"date":"2023-04-06","current":-1.043077,"twenty":-70.569383,"median":-14.066248,"eighty":-5.910288,"marketCap":20331189},{"date":"2023-04-14","current":-1.321345,"twenty":-64.954263,"median":-14.066248,"eighty":-5.744966,"marketCap":21700767},{"date":"2023-04-21","current":-1.310948,"twenty":-60.422571,"median":-13.83181,"eighty":-5.658826,"marketCap":21530015},{"date":"2023-04-28","current":-1.398249,"twenty":-47.962314,"median":-13.730013,"eighty":-5.59802,"marketCap":22963775},{"date":"2023-05-05","current":-1.498124,"twenty":-47.962314,"median":-13.705049,"eighty":-5.49939,"marketCap":24604044},{"date":"2023-05-12","current":-1.558049,"twenty":-47.962314,"median":-13.64563,"eighty":-5.24151,"marketCap":25588206},{"date":"2023-05-19","current":-1.963531,"twenty":-47.962314,"median":-13.355558,"eighty":-3.791935,"marketCap":24056194},{"date":"2023-05-26","current":-1.809834,"twenty":-47.962314,"median":-13.299333,"eighty":-3.683387,"marketCap":22173165},{"date":"2023-06-02","current":-1.797516,"twenty":-46.033619,"median":-13.23074,"eighty":-3.614639,"marketCap":22022260},{"date":"2023-06-09","current":-1.684251,"twenty":-43.485789,"median":-12.981103,"eighty":-3.299851,"marketCap":20634592},{"date":"2023-06-16","current":-1.609276,"twenty":-39.895803,"median":-12.731467,"eighty":-2.015739,"marketCap":19716041},{"date":"2023-06-23","current":-1.446742,"twenty":-38.369814,"median":-12.48183,"eighty":-1.965287,"marketCap":17724753},{"date":"2023-06-30","current":-1.344455,"twenty":-36.826895,"median":-12.48183,"eighty":-1.921295,"marketCap":16471587},{"date":"2023-07-07","current":-1.241901,"twenty":-36.397248,"median":-12.48183,"eighty":-1.877068,"marketCap":15215141},{"date":"2023-07-14","current":-1.204949,"twenty":-33.757987,"median":-12.48183,"eighty":-1.845821,"marketCap":14762426},{"date":"2023-07-21","current":-1.017513,"twenty":-33.635231,"median":-12.357585,"eighty":-1.824236,"marketCap":12466049},{"date":"2023-07-28","current":-0.905985,"twenty":-32.837315,"median":-12.357012,"eighty":-1.794379,"marketCap":11099674},{"date":"2023-08-04","current":-0.900255,"twenty":-31.425617,"median":-11.857738,"eighty":-1.773608,"marketCap":11029470},{"date":"2023-08-11","current":-0.63419,"twenty":-30.638859,"median":-11.386083,"eighty":-1.73785,"marketCap":7769771},{"date":"2023-08-18","current":-0.55807,"twenty":-30.103498,"median":-11.220378,"eighty":-1.68709,"marketCap":7062935},{"date":"2023-08-25","current":-0.523965,"twenty":-29.033151,"median":-11.097077,"eighty":-1.675707,"marketCap":6631311},{"date":"2023-09-01","current":-0.420938,"twenty":-28.224507,"median":-11.097077,"eighty":-1.659207,"marketCap":5327390},{"date":"2023-09-08","current":-0.350246,"twenty":-27.178685,"median":-11.097077,"eighty":-1.647519,"marketCap":4432713},{"date":"2023-09-15","current":-0.343819,"twenty":-25.922457,"median":-10.973777,"eighty":-1.629248,"marketCap":4351379},{"date":"2023-09-22","current":-0.313422,"twenty":-25.608909,"median":-10.850476,"eighty":-1.618329,"marketCap":3966668},{"date":"2023-09-29","current":-0.321326,"twenty":-23.64226,"median":-10.850476,"eighty":-1.601441,"marketCap":4066710},{"date":"2023-10-06","current":-0.289162,"twenty":-22.775869,"median":-10.688976,"eighty":-1.580196,"marketCap":3659632},{"date":"2023-10-13","current":-0.282767,"twenty":-22.573417,"median":-10.456607,"eighty":-1.555984,"marketCap":3578704},{"date":"2023-10-20","current":-0.29562,"twenty":-21.87715,"median":-10.357272,"eighty":-1.530122,"marketCap":3741373},{"date":"2023-10-27","current":-0.411298,"twenty":-20.708929,"median":-10.28233,"eighty":-1.525237,"marketCap":5205388},{"date":"2023-11-03","current":-0.385592,"twenty":-20.392025,"median":-10.008413,"eighty":-1.495062,"marketCap":4880052},{"date":"2023-11-10","current":-0.347032,"twenty":-20.25282,"median":-9.861161,"eighty":-1.453706,"marketCap":4392046},{"date":"2023-11-17","current":-0.527039,"twenty":-20.061981,"median":-9.742695,"eighty":-1.436505,"marketCap":6466068},{"date":"2023-11-24","current":-1.186185,"twenty":-20.052297,"median":-9.704796,"eighty":-1.418894,"marketCap":14552898},{"date":"2023-12-01","current":-0.739897,"twenty":-20.005723,"median":-9.704796,"eighty":-1.398059,"marketCap":9077550},{"date":"2023-12-08","current":-0.734025,"twenty":-19.855784,"median":-9.614269,"eighty":-1.379383,"marketCap":9005506},{"date":"2023-12-15","current":-0.757514,"twenty":-19.851774,"median":-9.529855,"eighty":-1.357844,"marketCap":9293682},{"date":"2023-12-22","current":-0.645942,"twenty":-19.450728,"median":-9.294762,"eighty":-1.3426,"marketCap":7924845},{"date":"2023-12-29","current":-0.734025,"twenty":-19.297293,"median":-9.178577,"eighty":-1.336307,"marketCap":9005506},{"date":"2024-01-05","current":-0.88681,"twenty":-18.799586,"median":-9.116636,"eighty":-1.327539,"marketCap":10879973},{"date":"2024-01-12","current":-0.924547,"twenty":-18.612428,"median":-9.098246,"eighty":-1.320866,"marketCap":11342950},{"date":"2024-01-19","current":-0.793298,"twenty":-18.4748,"median":-9.093511,"eighty":-1.311971,"marketCap":9732698},{"date":"2024-01-26","current":-0.812646,"twenty":-18.270731,"median":-8.999403,"eighty":-1.29484,"marketCap":9970081},{"date":"2024-02-02","current":-0.973886,"twenty":-18.114699,"median":-8.888116,"eighty":-1.287424,"marketCap":11948272},{"date":"2024-02-09","current":-0.838445,"twenty":-18.019487,"median":-8.794971,"eighty":-1.269673,"marketCap":10286591},{"date":"2024-02-16","current":-0.825545,"twenty":-17.817247,"median":-8.794971,"eighty":-1.256593,"marketCap":10128336},{"date":"2024-02-23","current":-0.780398,"twenty":-17.732346,"median":-8.790393,"eighty":-1.250053,"marketCap":9574443},{"date":"2024-03-01","current":-0.780398,"twenty":-17.646021,"median":-8.785645,"eighty":-1.245038,"marketCap":9574443},{"date":"2024-03-08","current":-0.806197,"twenty":-17.646021,"median":-8.666669,"eighty":-1.242787,"marketCap":9890953},{"date":"2024-03-15","current":-1.202078,"twenty":-17.560637,"median":-8.610667,"eighty":-1.232053,"marketCap":12640641},{"date":"2024-03-22","current":-1.061836,"twenty":-17.368294,"median":-8.491696,"eighty":-1.227587,"marketCap":11165900},{"date":"2024-03-28","current":-1.202078,"twenty":-17.227608,"median":-8.487276,"eighty":-1.21683,"marketCap":12640641},{"date":"2024-04-05","current":-1.282217,"twenty":-17.050112,"median":-8.393504,"eighty":-1.215841,"marketCap":13483351},{"date":"2024-04-12","current":-1.151992,"twenty":-16.459254,"median":-8.335718,"eighty":-1.212048,"marketCap":12113948},{"date":"2024-04-19","current":-1.051818,"twenty":-16.10474,"median":-8.21272,"eighty":-1.209834,"marketCap":11060561},{"date":"2024-04-26","current":-1.592754,"twenty":-15.910707,"median":-7.968666,"eighty":-1.204842,"marketCap":16748850},{"date":"2024-05-03","current":-1.151992,"twenty":-15.82702,"median":-7.731497,"eighty":-1.203538,"marketCap":12113948},{"date":"2024-05-10","current":-1.101905,"twenty":-15.82702,"median":-7.634408,"eighty":-1.200338,"marketCap":11587254},{"date":"2024-05-17","current":-1.061836,"twenty":-15.734838,"median":-7.48459,"eighty":-1.18456,"marketCap":11165900},{"date":"2024-05-24","current":-0.858149,"twenty":-15.582152,"median":-7.430234,"eighty":-1.178636,"marketCap":10834083},{"date":"2024-05-31","current":-0.715889,"twenty":-15.563236,"median":-7.382,"eighty":-1.173177,"marketCap":9038058},{"date":"2024-06-07","current":-0.658318,"twenty":-15.563236,"median":-7.319625,"eighty":-1.165754,"marketCap":8311221},{"date":"2024-06-14","current":-0.711685,"twenty":-15.563236,"median":-7.290579,"eighty":-1.161858,"marketCap":8984974},{"date":"2024-06-21","current":-0.630227,"twenty":-15.512687,"median":-7.276703,"eighty":-1.151992,"marketCap":7956573},{"date":"2024-06-28","current":-0.631856,"twenty":-15.351334,"median":-7.261532,"eighty":-1.146431,"marketCap":7977141},{"date":"2024-07-05","current":-0.62594,"twenty":-15.258759,"median":-7.232486,"eighty":-1.131572,"marketCap":7902447},{"date":"2024-07-12","current":-0.703024,"twenty":-15.199238,"median":-7.174394,"eighty":-1.12194,"marketCap":8875638},{"date":"2024-07-15","current":-0.678244,"twenty":-15.199238,"median":-7.116302,"eighty":-1.119798,"marketCap":8562788},{"date":"2024-08-02","current":-0.716281,"twenty":-14.887513,"median":-6.941989,"eighty":-1.109939,"marketCap":9043003},{"date":"2024-08-09","current":-0.651797,"twenty":-14.669052,"median":-6.792928,"eighty":-1.091888,"marketCap":8228892},{"date":"2024-08-16","current":-0.751707,"twenty":-14.498482,"median":-6.738702,"eighty":-1.08187,"marketCap":8549966},{"date":"2024-08-23","current":-0.748193,"twenty":-14.327911,"median":-6.622518,"eighty":-1.078179,"marketCap":8510005},{"date":"2024-08-30","current":-0.721532,"twenty":-14.296916,"median":-6.562136,"eighty":-1.072328,"marketCap":8206761},{"date":"2024-09-06","current":-0.68602,"twenty":-14.296916,"median":-6.469219,"eighty":-1.069821,"marketCap":7802835},{"date":"2024-09-13","current":-0.727328,"twenty":-14.296916,"median":-6.411345,"eighty":-1.061836,"marketCap":8272684},{"date":"2024-09-20","current":-0.696727,"twenty":-14.296916,"median":-6.353237,"eighty":-1.054133,"marketCap":7924624},{"date":"2024-09-27","current":-0.695504,"twenty":-14.296916,"median":-6.321565,"eighty":-1.044289,"marketCap":7910709},{"date":"2024-10-04","current":-0.671793,"twenty":-14.118204,"median":-6.222154,"eighty":-1.036389,"marketCap":7641025},{"date":"2024-10-11","current":-0.50013,"twenty":-14.066248,"median":-6.067323,"eighty":-1.01984,"marketCap":5688519},{"date":"2024-10-18","current":-0.576109,"twenty":-14.066248,"median":-5.964847,"eighty":-1.014835,"marketCap":6552704},{"date":"2024-10-25","current":-0.757678,"twenty":-13.83181,"median":-5.814279,"eighty":-0.991815,"marketCap":8617878},{"date":"2024-10-31","current":-0.758731,"twenty":-13.730013,"median":-5.719235,"eighty":-0.980335,"marketCap":8629864},{"date":"2024-11-08","current":-0.571578,"twenty":-13.730013,"median":-5.630104,"eighty":-0.95093,"marketCap":6501164},{"date":"2024-11-15","current":-0.58064,"twenty":-13.64563,"median":-5.578452,"eighty":-0.920835,"marketCap":6604243},{"date":"2024-11-22","current":-0.799583,"twenty":-13.418762,"median":-5.497016,"eighty":-0.900947,"marketCap":6591059},{"date":"2024-11-29","current":-0.787271,"twenty":-13.355558,"median":-5.239709,"eighty":-0.895748,"marketCap":6489564},{"date":"2024-12-06","current":-0.794995,"twenty":-13.233835,"median":-3.78108,"eighty":-0.88234,"marketCap":6553235},{"date":"2024-12-13","current":-0.764989,"twenty":-13.105921,"median":-3.672532,"eighty":-0.851444,"marketCap":6305897},{"date":"2024-12-20","current":-0.769,"twenty":-12.89,"median":-3.527801,"eighty":-0.838445,"marketCap":6338957},{"date":"2024-12-27","current":-0.830348,"twenty":-12.631501,"median":-3.093611,"eighty":-0.825442,"marketCap":6844653},{"date":"2025-01-03","current":-0.952598,"twenty":-12.48183,"median":-2.023095,"eighty":-0.825442,"marketCap":7852372},{"date":"2025-01-10","current":-0.793212,"twenty":-12.48183,"median":-1.965726,"eighty":-0.824584,"marketCap":6538542},{"date":"2025-01-17","current":-0.818613,"twenty":-12.48183,"median":-1.915211,"eighty":-0.816226,"marketCap":6747922},{"date":"2025-01-24","current":-0.79247,"twenty":-12.48183,"median":-1.86954,"eighty":-0.811335,"marketCap":6532419},{"date":"2025-01-31","current":-0.772417,"twenty":-12.48183,"median":-1.845312,"eighty":-0.806197,"marketCap":6367119},{"date":"2025-02-07","current":-0.680321,"twenty":-12.48183,"median":-1.822285,"eighty":-0.800781,"marketCap":5607963},{"date":"2025-02-14","current":-0.62239,"twenty":-12.48183,"median":-1.794164,"eighty":-0.798943,"marketCap":5130429},{"date":"2025-02-21","current":-0.868969,"twenty":-12.48183,"median":-1.774601,"eighty":-0.794876,"marketCap":7163009},{"date":"2025-02-28","current":-1.185362,"twenty":-12.48183,"median":-1.738663,"eighty":-0.794876,"marketCap":9771079},{"date":"2025-03-07","current":-0.94517,"twenty":-12.48183,"median":-1.686929,"eighty":-0.794817,"marketCap":7791150},{"date":"2025-03-14","current":-1.021967,"twenty":-12.48183,"median":-1.674611,"eighty":-0.794817,"marketCap":8424189},{"date":"2025-03-21","current":-0.987802,"twenty":-12.48183,"median":-1.658971,"eighty":-0.794817,"marketCap":8142566},{"date":"2025-03-28","current":-1.186848,"twenty":-12.48183,"median":-1.64007,"eighty":-0.794817,"marketCap":9783324},{"date":"2025-04-04","current":-1.358413,"twenty":-12.48183,"median":-1.633375,"eighty":-0.794817,"marketCap":11197559},{"date":"2025-04-11","current":-1.559687,"twenty":-12.48183,"median":-1.622615,"eighty":-0.794876,"marketCap":12856684},{"date":"2025-04-17","current":-2.422481,"twenty":-12.48183,"median":-1.616463,"eighty":-0.794876,"marketCap":11877127},{"date":"2025-04-25","current":-2.795995,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":13708421},{"date":"2025-05-02","current":-5.324769,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":15499093},{"date":"2025-05-09","current":-6.823976,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":19862916},{"date":"2025-05-16","current":-6.668915,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":19411570},{"date":"2025-05-23","current":-6.755518,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":19663651},{"date":"2025-05-30","current":-7.816302,"twenty":-12.357356,"median":-1.615552,"eighty":-0.794817,"marketCap":22751332},{"date":"2025-06-06","current":-8.374609,"twenty":-12.307084,"median":-1.615552,"eighty":-0.794817,"marketCap":24376428},{"date":"2025-06-13","current":-10.328685,"twenty":-11.690443,"median":-1.615552,"eighty":-0.794817,"marketCap":30064261},{"date":"2025-06-20","current":-10.831161,"twenty":-11.321673,"median":-1.612414,"eighty":-0.794757,"marketCap":31526846},{"date":"2025-06-27","current":-12.22693,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":35589584},{"date":"2025-07-03","current":-17.363357,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":50540460},{"date":"2025-07-11","current":-18.703294,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":54440689},{"date":"2025-07-18","current":-19.987401,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":58178408},{"date":"2025-07-25","current":-18.144987,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":52815594},{"date":"2025-08-01","current":-13.399375,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":39002284},{"date":"2025-08-08","current":-14.627651,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":42577494},{"date":"2025-08-15","current":-16.411544,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":69345996},{"date":"2025-08-22","current":-16.411544,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":69345996},{"date":"2025-08-29","current":-16.627486,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":70258443},{"date":"2025-09-05","current":-14.684013,"twenty":-11.220378,"median":-1.609276,"eighty":-0.794698,"marketCap":62046417},{"date":"2025-09-12","current":-14.95394,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":63186976},{"date":"2025-09-19","current":-14.684013,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":62046417},{"date":"2025-09-26","current":-16.843427,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":71170890},{"date":"2025-10-03","current":-16.303574,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":68889772},{"date":"2025-10-10","current":-17.761178,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":75048792},{"date":"2025-10-17","current":-15.76372,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":66608654},{"date":"2025-10-24","current":-15.76372,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":66608654},{"date":"2025-10-31","current":-15.223867,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":64327536},{"date":"2025-11-07","current":-12.257134,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":64783759},{"date":"2025-11-14","current":-12.998791,"twenty":-11.230993,"median":-1.612414,"eighty":-0.794757,"marketCap":65997254},{"date":"2025-11-21","current":-12.348851,"twenty":-11.230993,"median":-1.612414,"eighty":-0.794757,"marketCap":62697391},{"date":"2025-11-28","current":-12.580973,"twenty":-11.230993,"median":-1.612414,"eighty":-0.794757,"marketCap":63875914},{"date":"2025-12-05","current":-11.745336,"twenty":-11.230993,"median":-1.612414,"eighty":-0.794757,"marketCap":59633233},{"date":"2025-12-12","current":-10.445457,"twenty":-11.167576,"median":-1.612414,"eighty":-0.794757,"marketCap":53033508},{"date":"2025-12-19","current":-9.470548,"twenty":-11.097077,"median":-1.612414,"eighty":-0.794757,"marketCap":48083713},{"date":"2025-12-26","current":-10.816851,"twenty":-11.097077,"median":-1.612414,"eighty":-0.794757,"marketCap":54919143},{"date":"2026-01-02","current":-9.888366,"twenty":-11.097077,"median":-1.612414,"eighty":-0.794757,"marketCap":50205054},{"date":"2026-01-09","current":-10.445457,"twenty":-10.973777,"median":-1.612414,"eighty":-0.794757,"marketCap":53033508},{"date":"2026-01-16","current":-9.516972,"twenty":-10.905158,"median":-1.612414,"eighty":-0.794757,"marketCap":48319418},{"date":"2026-01-23","current":-9.656245,"twenty":-10.850476,"median":-1.612414,"eighty":-0.794757,"marketCap":49026531},{"date":"2026-01-30","current":-9.656245,"twenty":-10.850476,"median":-1.612414,"eighty":-0.794757,"marketCap":49026531},{"date":"2026-02-06","current":-7.42788,"twenty":-10.828299,"median":-1.612414,"eighty":-0.794757,"marketCap":37712716},{"date":"2026-02-13","current":-8.122087,"twenty":-10.716998,"median":-1.612414,"eighty":-0.794757,"marketCap":41237331},{"date":"2026-02-20","current":-7.441194,"twenty":-10.54144,"median":-1.612414,"eighty":-0.794757,"marketCap":37780309},{"date":"2026-02-27","current":-6.273948,"twenty":-10.421752,"median":-1.612414,"eighty":-0.794757,"marketCap":31853986},{"date":"2026-03-06","current":-4.402467,"twenty":-10.352609,"median":-1.612414,"eighty":-0.794757,"marketCap":34817148},{"date":"2026-03-13","current":-4.280476,"twenty":-10.280435,"median":-1.612414,"eighty":-0.794757,"marketCap":33852379},{"date":"2026-03-20","current":-4.030522,"twenty":-10.118,"median":-1.612414,"eighty":-0.794757,"marketCap":31875598},{"date":"2026-03-27","current":-3.311901,"twenty":-9.981215,"median":-1.612414,"eighty":-0.794757,"marketCap":26192351},{"date":"2026-04-02","current":-3.37439,"twenty":-9.901457,"median":-1.612414,"eighty":-0.794757,"marketCap":26686547},{"date":"2026-04-10","current":-4.467943,"twenty":-9.837072,"median":-1.612414,"eighty":-0.794757,"marketCap":35334965},{"date":"2026-04-17","current":-3.843056,"twenty":-9.753767,"median":-1.612414,"eighty":-0.794757,"marketCap":30393012},{"date":"2026-04-24","current":-3.561856,"twenty":-9.656245,"median":-1.612414,"eighty":-0.794757,"marketCap":28169133},{"date":"2026-05-01","current":-3.218168,"twenty":-9.604901,"median":-1.612414,"eighty":-0.794757,"marketCap":25451058},{"date":"2026-05-08","current":-3.436879,"twenty":-9.556177,"median":-1.612414,"eighty":-0.794757,"marketCap":27180742},{"date":"2026-05-15","current":-3.37439,"twenty":-9.464437,"median":-1.612414,"eighty":-0.794757,"marketCap":26686547},{"date":"2026-05-22","current":-3.179405,"twenty":-9.400342,"median":-1.612414,"eighty":-0.794757,"marketCap":27427840},{"date":"2026-05-29","current":-4.130239,"twenty":-9.323732,"median":-1.609276,"eighty":-0.794698,"marketCap":35630419},{"date":"2026-06-05","current":-4.218116,"twenty":-9.266185,"median":-1.612414,"eighty":-0.794757,"marketCap":36388513},{"date":"2026-06-12","current":-3.837314,"twenty":-9.166959,"median":-1.612414,"eighty":-0.794757,"marketCap":33103439},{"date":"2026-06-18","current":-3.983777,"twenty":-8.994573,"median":-1.612414,"eighty":-0.794757,"marketCap":34366929},{"date":"2026-06-26","current":-4.247409,"twenty":-8.830023,"median":-1.609276,"eighty":-0.794698,"marketCap":36641211},{"date":"2026-07-02","current":-5.184768,"twenty":-8.780896,"median":-1.609276,"eighty":-0.794698,"marketCap":44727547},{"date":"2026-07-10","current":-4.247409,"twenty":-8.597932,"median":-1.609276,"eighty":-0.794698,"marketCap":36641211},{"date":"2026-07-17","current":-3.544389,"twenty":-8.462534,"median":-1.609276,"eighty":-0.794698,"marketCap":30576459},{"date":"2026-07-24","current":-3.515097,"twenty":-8.303464,"median":-1.609276,"eighty":-0.794698,"marketCap":30323761},{"date":"2026-07-31","current":-3.163587,"twenty":-8.214187,"median":-1.608071,"eighty":-0.794418,"marketCap":27291385},{"date":"2026-08-07","current":-2.987832,"twenty":-8.129073,"median":-1.608071,"eighty":-0.794418,"marketCap":25775197},{"date":"2026-08-14","current":-3.411439,"twenty":-7.951395,"median":-1.608071,"eighty":-0.794418,"marketCap":24243847},{"date":"2026-08-21","current":-3.246196,"twenty":-7.951395,"median":-1.608071,"eighty":-0.794418,"marketCap":23069521},{"date":"2026-08-28","current":-2.902571,"twenty":-7.951395,"median":-1.608071,"eighty":-0.794418,"marketCap":20627507}],"updateTime":1788131512904},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABVC\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635584660","title":"ABVC BioPharma delays filing quarterly report for period ended March 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635584660","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635584660?lang=en_us&edition=fundamental","pubTime":"2026-05-16 05:04","pubTimestamp":1778879076,"startTime":"0","endTime":"0","summary":"ABVC BioPharma filed a Form 12b-25 late notice for its quarterly report for period ended March 31, 2026.Form 10-Q missed deadline as management was unable to finalize report and XBRL exhibit without unreasonable effort or expense.Filing targeted within SEC extension window of five calendar days following prescribed due date.Notice indicated no expected significant change in results of operations versus corresponding prior-year period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABVC Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely responsible f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDLnMYsZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635125427","title":"Press Release: Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301","url":"https://stock-news.laohu8.com/highlight/detail?id=2635125427","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635125427?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:00","pubTimestamp":1778760000,"startTime":"0","endTime":"0","summary":"KANSAS CITY, Kan., May 14, 2026  -- Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release  drug delivery platform to develop a pipeline of next-generation products, today reported financial results for the quarter ended March 31, 2026, and provided a corporate update.\"Cingulate remains focused on disciplined execution in 2026 and we believe we are well positioned to bring our lead ADHD asset, CTx-1301, to market,\" said Cingulate CEO Shane J. Schaffer. \"We continue to engage constructively with the FDA on our new drug application while advancing commercial readiness and manufacturing capabilities, and believe our current resources provide an extended cash runway into 2027.\". process validation batch preparation for CTx-1301, which will serve as","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4555","BK4604","ABVC","CING","LABU","BK4099","TM","BK4588","BK4007","ADHD","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634021113","title":"Collegium Pharmaceutical Completes AZSTARYS ADHD Business Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2634021113","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634021113?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:33","pubTimestamp":1778589207,"startTime":"0","endTime":"0","summary":"Collegium Pharmaceutical ( ($COLL) ) has provided an update. On May 12, 2026, Collegium Pharmaceutical completed its previously announced $650 mill...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/collegium-pharmaceutical-completes-azstarys-adhd-business-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/collegium-pharmaceutical-completes-azstarys-adhd-business-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVC","ADHD","COLL","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634928215","title":"Press Release: Collegium Completes Acquisition of AZSTARYS(R) from Corium Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2634928215","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634928215?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:31","pubTimestamp":1778585460,"startTime":"0","endTime":"0","summary":"-- Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium's Existing ADHD Portfolio --. -- Extends Collegium's Long-Term Revenue Outlook; AZSTARYS has Expected Patent Protection Through 2037 --. -- Collegium Raises 2026 Financial Guidance to Reflect Expected Immediate Accretion from Acquisition --. -- 2026 Total Product Revenues, Net Expected in the Range of $865 to $895 Million and Adjusted EBITDA in the Range of $475 to $500 Million --. \"We are pleased to complete the acquisition of AZSTARYS, a highly strategic addition to our portfolio that strengthens our position in ADHD and further reinforces our long-standing commitment to improving patient care and delivering shareholder value,\" said Vikram Karnani, President and Chief Executive Officer. \"AZSTARYS is a complementary and differentiated therapy that expands the treatment options we can offer patients and prescribers, and we look forward to rapidly integrating it into our existing comm","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","ABVC","LENZ","COLL","BK4539","ADHD","BK4022","BK4139","CNS","BK4135","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634470661","title":"Yukiguni Maitake Sees FY Net Y2.54B","url":"https://stock-news.laohu8.com/highlight/detail?id=2634470661","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634470661?lang=en_us&edition=fundamental","pubTime":"2026-05-11 14:30","pubTimestamp":1778481000,"startTime":"0","endTime":"0","summary":"Yukiguni Maitake Co. Ltd. also released the following forecasts:. This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149347","title":"Press Release: Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149347","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149347?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153400,"startTime":"0","endTime":"0","summary":"-- Generated Quarterly Net Revenues of $193.5 Million, Up 9% Year-over-Year --. -- Generated JORNAY PM Quarterly Net Revenue of $38.9 Million, Up 36% Year-over-Year --. -- On Track to Close Acquisition of AZSTARYS in Second Quarter of 2026, Adding Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium's Existing ADHD Portfolio --. -- Generated Quarterly Pain Portfolio Net Revenues of $154.6 Million, Up 4% Year-over-Year --. -- Ended Q1'26 with Cash, Cash Equivalents and Marketable Securities of $421.8 Million --. -- Reaffirmed Full-Year 2026 Guidance for the Current Business --. -- Generated JORNAY PM net revenue of $38.9 million, up 36% year-over-year. -- JORNAY PM prescriptions reached an all-time high in the 202","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065732104.USD","PRGS","BK4022","ABVC","BK4007","AG","R","BK4097","BK4139","COLL","BK4210","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633154088","title":"Regencell Bioscience Holdings Faces Federal Securities Lawsuit Over Alleged Market Manipulation Disclosures","url":"https://stock-news.laohu8.com/highlight/detail?id=2633154088","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633154088?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:21","pubTimestamp":1778098896,"startTime":"0","endTime":"0","summary":"Regencell (RGC) promoted a traditional Chinese medicine approach to treating ADHD and autism. A small company with twelve employees, no approved or...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/regencell-bioscience-holdings-faces-federal-securities-lawsuit-over-alleged-market-manipulation-disclosures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/regencell-bioscience-holdings-faces-federal-securities-lawsuit-over-alleged-market-manipulation-disclosures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMF","RGC","ABVC","US30Y.BOND","US5Y.BOND","US6M.BOND","US2Y.BOND","TLTW","US10Y.BOND","US7Y.BOND","BK4139","US3Y.BOND","TLT","BK4007","BK4539","US12M.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632229953","title":"Alto Neuroscience presents Phase 2a data for ALTO-207 in MDD","url":"https://stock-news.laohu8.com/highlight/detail?id=2632229953","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632229953?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:31","pubTimestamp":1777897864,"startTime":"0","endTime":"0","summary":"Alto Neuroscience (ANRO) announced the presentation of data from a randomized, single-blind, placebo-controlled Phase 2a trial of ALTO-207 in patie...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alto-neuroscience-presents-phase-2a-data-for-alto-207-in-mdd-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alto-neuroscience-presents-phase-2a-data-for-alto-207-in-mdd-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALTO","BK4139","BK4138","ABVC","ANRO","BK4007","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632998647","title":"Regencell Bioscience Holdings Faces Investor Lawsuit Alleging Securities Fraud Tied to DOJ Investigation and Stock Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2632998647","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632998647?lang=en_us&edition=fundamental","pubTime":"2026-05-02 03:47","pubTimestamp":1777664866,"startTime":"0","endTime":"0","summary":"Regencell (RGC) described itself as an early-stage bioscience company developing traditional Chinese medicine (“TCM”) treatments for ADHD and autis...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/regencell-bioscience-holdings-faces-investor-lawsuit-alleging-securities-fraud-tied-to-doj-investigation-and-stock-volatility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/regencell-bioscience-holdings-faces-investor-lawsuit-alleging-securities-fraud-tied-to-doj-investigation-and-stock-volatility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVC","BK4139","BK4007","RGC","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631952919","title":"Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2631952919","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631952919?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:30","pubTimestamp":1777494600,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., April  29, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/29/3284304/0/en/Neuronetics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4139","ABVC","STIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626902208","title":"Humanwell Healthcare Subsidiary Gets China Nod for ADHD Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2626902208","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626902208?lang=en_us&edition=fundamental","pubTime":"2026-04-09 16:37","pubTimestamp":1775723836,"startTime":"0","endTime":"0","summary":"China's drug regulator approved the dextromethorphan hydrochloride sustained-release capsules produced by Humanwell Healthcare  subsidiary Yichang Humanwell Pharmaceutical.The approval is for the indication of attention deficit hyperactivity disorder in children aged six years and older, according to a Thursday filing with the Shanghai bourse.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK0239","BK0070","XLV","ABVC","BK0188","LU0029874061.USD","BK0185","BK4139","ADHD","LU0128526141.USD","XBI","BK0028","BK0096","HCSG","BK0012","600079","LABU","BK4581","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622967803","title":"ABVC BioPharma Shareholders Back Board, Equity Plan Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2622967803","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622967803?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:47","pubTimestamp":1774644430,"startTime":"0","endTime":"0","summary":"The latest update is out from ABVC BioPharma ( ($ABVC) ). On March 26, 2026, ABVC BioPharma held its 2026 annual shareholder meeting, where investo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abvc-biopharma-shareholders-back-board-equity-plan-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abvc-biopharma-shareholders-back-board-equity-plan-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","EQR","ABVC","BK4139","BK4215","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622870708","title":"ABVC Biopharma held annual shareholder meeting; quorum reached with 10.6 million shares represented by proxy","url":"https://stock-news.laohu8.com/highlight/detail?id=2622870708","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622870708?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:06","pubTimestamp":1774641992,"startTime":"0","endTime":"0","summary":"ABVC BioPharma held its annual shareholder meeting on March 26, 2026.Shareholders approved the re-election of 11 directors to the board.An increase to the Amended and Restated 2016 Equity Incentive Plan to set the aggregate share reserve at 15% of issued and outstanding common stock as of the meeting date was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABVC Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL8VgnJw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622989619","title":"Press Release: LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2622989619","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622989619?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:05","pubTimestamp":1774555500,"startTime":"0","endTime":"0","summary":"Reported positive results from potentially registrational Phase 2 trial of. Advanced LB-102 into late-stage development in multiple indications with initiation of. a pivotal Phase 3 NOVA-2 trial in schizophrenia, and Phase 2 ILLUMINATE-1 trial. Announced pipeline expansion with plans to initiate a Phase 2 trial of LB-102 for the. adjunctive treatment of major depressive disorder  in early 2027. Cash, cash equivalents, and investments of $295.2 million as of December 31, 2025,and proceeds from recent $100 million private placement, expected to provide cash runway into Q2 2029. The Company is building a pipeline that leverages the broad therapeutic potential of LB-102, which has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States.-- Reported positive results in January 2025 from a robust 359 patient Phase. 2 trial  of LB-102 in acute schizophrenia. The trial met the. baseline in the Positive and Negative Syndrome Scale  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4233","BK4139","LB","BK4213","ABVC","BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622885239","title":"BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD","url":"https://stock-news.laohu8.com/highlight/detail?id=2622885239","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622885239?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:30","pubTimestamp":1774524600,"startTime":"0","endTime":"0","summary":"BURLINGTON, Mass. and JERUSALEM, March  26, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/26/3262880/17676/en/BrainsWay-Completes-Additional-6-Million-Milestone-Based-Investment-in-Neurolief-Ltd-Following-FDA-Approval-of-Proliv-Rx-System-for-MDD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4139","BK4149","FSS","LU0054578231.USD","BK4585","ABVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620782743","title":"Collegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2620782743","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620782743?lang=en_us&edition=fundamental","pubTime":"2026-03-20 18:16","pubTimestamp":1774001760,"startTime":"0","endTime":"0","summary":"Collegium Pharmaceutical, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Brandon Folkes from H.C. Wainwright ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/collegium-strategic-azstarys-acquisition-underpins-adhd-franchise-expansion-and-supports-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/collegium-strategic-azstarys-acquisition-underpins-adhd-franchise-expansion-and-supports-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVC","ADHD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620247205","title":"Press Release: Collegium to Acquire AZSTARYS(R) from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory","url":"https://stock-news.laohu8.com/highlight/detail?id=2620247205","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620247205?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:00","pubTimestamp":1773921600,"startTime":"0","endTime":"0","summary":"-- Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium's Existing ADHD Portfolio --. -- Enables Greater Impact Across ADHD Patient Communities --. -- AZSTARYS Expected to Generate Over $50 Million in Second Half 2026 Pro Forma Net Revenue --. \"Over the past two years, our team has worked hard to establish AZSTARYS as a leading treatment option for patients with ADHD through innovative patient access solutions and analytically driven execution,\" said Todd Smith, Chief Executive Officer of Corium Therapeutics. \"We are proud of the progress that has been achieved and believe Collegium is well positioned to build on that foundation and continue expanding its reach.\". -- Strategically aligns with Collegium's mission of building a leading,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ADHD","ABVC","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620846253","title":"Press Release: Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2620846253","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620846253?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:00","pubTimestamp":1773835200,"startTime":"0","endTime":"0","summary":"KANSAS CITY, Kan., March 18, 2026  -- Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release  drug delivery platform to develop a pipeline of next-generation products, today reported financial results for the quarter ended December 31, 2025, and provided a corporate update. Highlights include recent U.S. and European patent developments, the closing of a $12 million private investment, and the acceptance of a New Drug Application  for its lead candidate, CTx-1301 .Cingulate received a European patent for CTx-1301 covering the specificity of its tri-modal, precision-timed pulsatile release profile for the treatment of ADHD. The patent , granted on December 17, 2025, extends protection through May 2042 and is expected to be validated in more than 30 European territories, including the United Kingdom.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","ABVC","BK4604","BK4139","CING","ADHD","PIPE","TM","BK4007","BK4585","BK4099","BK4555","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616372794","title":"ABVC posts FY 2025 net loss of USD 8.4 million (59% increase)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616372794","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616372794?lang=en_us&edition=fundamental","pubTime":"2026-03-04 06:02","pubTimestamp":1772575364,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABVC Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL2Bg3gf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616941372","title":"Abvc Biopharma Says Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon; Reports Material Weakness In Internal Controls Over Financial Reporting For FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2616941372","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616941372?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:54","pubTimestamp":1772574879,"startTime":"0","endTime":"0","summary":"- SEC Filing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51021667/abvc-biopharma-says-quarterly-period-ended-september-2025-financial-statements-should-not-be-relied","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Abvc Biopharma Says Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon; Reports Material Weakness In Internal Controls Over Financial Reporting For FY25","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABVC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":63,"code":"91000000","status":"200"}]}}